NTHL1 Gene Familial Adenomatous Polyposis Type 3 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Cancer Risk
The NTHL1 Gene Familial Adenomatous Polyposis Type 3 NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This advanced diagnostic examination specifically targets mutations in the NTHL1 gene, which plays a critical role in DNA base excision repair mechanisms. When this gene malfunctions, individuals face significantly elevated risks for developing multiple colorectal adenomatous polyps and various cancer types throughout their lifetime.
What Does This Test Measure?
This sophisticated genetic analysis utilizes Next-Generation Sequencing (NGS) technology to comprehensively examine the entire NTHL1 gene sequence. The test specifically detects:
- Pathogenic variants and mutations in the NTHL1 gene
- Genetic alterations associated with base excision repair deficiencies
- Inherited mutations that increase cancer susceptibility
- Specific genetic markers for Familial Adenomatous Polyposis Type 3
Who Should Consider This Test?
This genetic screening is particularly recommended for individuals exhibiting:
- Personal history of multiple colorectal adenomatous polyps
- Family history of colorectal cancer or polyposis syndromes
- Early-onset colorectal cancer diagnosis (before age 50)
- Multiple primary cancers in personal medical history
- Unexplained gastrointestinal symptoms with family cancer patterns
- Known NTHL1 gene mutations in close family members
Clinical Benefits and Importance
Undergoing NTHL1 genetic testing provides numerous critical advantages:
- Early Risk Identification: Detect genetic predisposition before symptom development
- Personalized Screening: Tailor cancer surveillance protocols based on genetic risk
- Family Planning: Make informed reproductive decisions with genetic counseling
- Preventive Strategies: Implement targeted prevention measures for at-risk individuals
- Treatment Guidance: Inform therapeutic decisions for affected individuals
Understanding Your Test Results
Genetic test results require professional interpretation by qualified genetic counselors and medical specialists:
- Positive Result: Indicates presence of NTHL1 gene mutation, requiring enhanced cancer surveillance and preventive measures
- Negative Result: No detected mutation, though continued routine screening may still be recommended
- Variant of Uncertain Significance: Genetic changes with unknown clinical impact requiring ongoing research and monitoring
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Test Specifications
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
- Methodology: Next-Generation Sequencing (NGS) Technology
- Specialty: Oncology Genetics
Pre-Test Requirements
Before undergoing testing, patients must provide:
- Complete clinical history documentation
- Participation in genetic counseling session
- Development of detailed family pedigree chart
- Discussion of potential implications and management options
Nationwide Accessibility
We maintain comprehensive testing facilities across major metropolitan areas throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to advanced genetic testing services regardless of your location.
Take Control of Your Genetic Health
Understanding your genetic predisposition to cancer can be life-changing. Early detection through NTHL1 gene testing empowers you and your healthcare providers to implement proactive surveillance and prevention strategies. Don’t wait for symptoms to appear – take the first step toward personalized cancer risk management today.
Book your NTHL1 Gene Familial Adenomatous Polyposis Type 3 NGS Genetic DNA Test now by calling our dedicated genetic counseling team at +1(267) 388-9828 or schedule your appointment online. Our experienced professionals will guide you through the testing process and help you understand your results within the context of your personal and family medical history.
